Arbutus Biopharma Corp
(ABUS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,408 | 37,412 | 37,076 | 36,330 | 31,846 |
| Marketable Securities | 71,294 | 60,676 | 75,631 | 86,293 | 95,948 |
| Receivables | 905 | 1,025 | 1,182 | 2,409 | 1,608 |
| TOTAL | $97,442 | $103,119 | $116,808 | $127,316 | $132,777 |
| Non-Current Assets | |||||
| PPE Net | 137 | 148 | 168 | 3,309 | 3,556 |
| Investments And Advances | 0 | 0 | 0 | 0 | 2,964 |
| Other Non-Current Assets | 131 | 0 | 34 | 1,082 | 1,144 |
| TOTAL | $268 | $148 | $202 | $4,391 | $7,664 |
| Total Assets | $97,710 | $103,267 | $117,010 | $131,707 | $140,441 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,653 | 4,508 | 12,109 | 7,564 | 7,544 |
| TOTAL | $5,184 | $5,022 | $19,431 | $15,618 | $18,923 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 6,759 | 7,571 | 10,911 |
| Other Non-Current Liabilities | 15,127 | 15,269 | 15,559 | 15,860 | 14,628 |
| TOTAL | $15,127 | $15,269 | $18,422 | $18,723 | $14,628 |
| Total Liabilities | $20,311 | $20,291 | $37,853 | $34,341 | $33,551 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 192,324 | 191,699 | 191,527 | 191,480 | 189,492 |
| Common Shares | 1,418,560 | 1,417,110 | 1,416,332 | 1,410,025 | 1,407,595 |
| Retained earnings | -1,376,317 | -1,368,575 | -1,371,098 | -1,346,572 | -1,334,040 |
| Other shareholders' equity | -48,129 | -48,187 | -48,166 | -48,135 | -48,090 |
| TOTAL | $77,399 | $82,976 | $79,157 | $97,366 | $106,890 |
| Total Liabilities And Equity | $97,710 | $103,267 | $117,010 | $131,707 | $140,441 |